NKCL Master

News

EN
CN
KR

EN

[Interview] Leading the Popularization of NK cell immunotherapy with differentiated immune cell culture technology

Shin Dong-hwa, Chairman of NKCL Bio Group ◆ Please give us a brief introduction of yourself. Hello, this is SHIN, DONG-HWA, the president of NKCL Bio Group Inc. NKCL Bio Group Inc. is a company that leads the "Personalized Immune Care" market by expanding its business area from various angles by exp...

NKCL | 2022.08.17 | 조회 193

NKCL Bio Group to introduce premium anti-aging solution program with NK cell culture technology

NKCL Bio Group Inc., a company specialized in NK cell culture technology, participated in the 1st International Virus and Bacteria Industry Expo (ViBac 2022) and unveiled a new concept of skin anti-aging solution using NK cells, which has attracted attention. This expo was hosted by Makers Union and ...

NKCL | 2022.07.21 | 조회 231

NKCL Bio Group Inc. participates in Korea’s first ‘2022 International Virus & Bacteria Industry Expo’

The 2022 Virus and Bacteria Trend Conference will be held, where domestic bacteria and virus-related companies come together to share the latest information and future strategies in the field. NKCL Bio Group Inc.(NKCL) has announced that it will participate in the '2022 International Virus and Bacter...

NKCL | 2022.07.14 | 조회 248

NKCL Bio Group Inc. concluded 3-party MOU with PnB Group, and MK Lab for distribution in the Philippines

NKCL Bio Group Inc. (NKCL) has announced that it had signed a 3-party MOU with PnB Group and MK Lab for distribution in the Philippines. PnB Group is a blockchain-based IT company, leading the Philippine market in fintech and IT solutions, and MK Lab is a company that operates K-beauty business in th...

NKCL | 2022.07.13 | 조회 222

‘NKCL Bio Group Inc.’ and ‘I Partners Group’ signed an MOU for innovative technology in the medical field

On July 4, NKCL Bio Group Inc. (CEO Shin, Donghwa) and I Partners Group (CEO Jung, Yiho) announced that they had signed an MOU for innovative technology in the medical field. I Partners Group is a specialized company that supplies programs that combine in various areas; such as, medical device, healt...

NKCL | 2022.07.11 | 조회 239

NKCL Bio Group has won the Grand Prize in the NK cell therapy category at the ‘2022 Consumer Selected Quality Satisfaction Award’

Dong-hwa Shin, chairman of NKCL Bio Group Inc.(NKCL Bio Group), was honored with the Grand Prize in the NK cell therapy category of the ‘2022 Consumer Selected Quality Satisfaction Award’. Celebrating its 13th anniversary this year, the '2022 Consumer Quality Satisfaction Award' is an award ceremon...

NKCL | 2022.06.30 | 조회 217

JTC Group of Companies visited NKCL Bio Group Inc. Headquarters

On June 28, the 'JTC Group of Companies ' visited NKCL Bio Group. NKCL Biogroup has explained its technological competitiveness of NK cell therapy, which is spotlighted as a next-generation anticancer treatment, to the 'JTC Group of Companies', and shared the future vision regarding the growth of imm...

NKCL | 2022.06.28 | 조회 219

About 50 Cambodian economic delegation visited NKCL Bio Group to discuss economic cooperation measures

On the 20th, the Cambodian economic delegation, the Reachsey Association, visiting Korea at the moment, visited NKCL Bio Group Inc. and announced that they discussed ways to cooperate in the bio industry between the two countries. The Cambodian economic delegation to Korea, the Reachsey Association, ...

NKCL | 2022.06.22 | 조회 209

NKCL Bio Group acquired ‘T-4 grade’ certification as an excellent technology company by Nice Evaluation Information

NKCL Bio Group Inc. (Chairman Dong-Hwa Shin, hereinafter referred to as NKCL) announced that it had acquired a ‘T-4’ grade, an excellent company certification at Technology Credit Bureau(TCB) by NICE evaluation information, a nationally accredited technology credit rating agency. The Tech Credit Bu...

NKCL | 2022.06.13 | 조회 206

NKCL Bio Group has won Grand Prize in ‘2022 Korea’s Influential CEO - Innovative Management Bio Sector’

On the 9th, NKCL Bio Group Inc.’s Chairman Dong-Hwa Shin has won the grand prize in the ‘2022 Korea’s Influential CEO- Innovative Management Bio Sector’ hosted by TV Chosun and Digital Chosun Ilbo. The '2022 Korea's Influential CEO' is awarded among the CEOs of companies and institutions during t...

NKCL | 2022.06.10 | 조회 221

1 [ 2 ] 3 4 5 6 7 8 9 10